Bifogade filer
Kurs & Likviditet
Kalender
2025-04-29 | Årsstämma |
2025-04-29 | Kvartalsrapport 2025-Q1 |
2025-02-28 | Bokslutskommuniké 2024 |
2024-10-31 | Kvartalsrapport 2024-Q3 |
2024-07-31 | Kvartalsrapport 2024-Q2 |
2024-04-30 | Kvartalsrapport 2024-Q1 |
2024-04-30 | Årsstämma |
2024-04-30 | X-dag ordinarie utdelning NNH 0.00 SEK |
2024-02-28 | Bokslutskommuniké 2023 |
2023-10-31 | Kvartalsrapport 2023-Q3 |
2023-07-31 | Kvartalsrapport 2023-Q2 |
2023-04-28 | X-dag ordinarie utdelning NNH 0.00 SEK |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-04-27 | Årsstämma |
2023-02-28 | Bokslutskommuniké 2022 |
2022-10-28 | Kvartalsrapport 2022-Q3 |
2022-07-29 | Kvartalsrapport 2022-Q2 |
2022-04-29 | X-dag ordinarie utdelning NNH 1.25 SEK |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-04-28 | Årsstämma |
2022-02-28 | Bokslutskommuniké 2021 |
2021-10-29 | Kvartalsrapport 2021-Q3 |
2021-07-30 | Kvartalsrapport 2021-Q2 |
2021-04-30 | X-dag ordinarie utdelning NNH 1.50 SEK |
2021-04-29 | Kvartalsrapport 2021-Q1 |
2021-04-29 | Årsstämma |
2021-02-26 | Bokslutskommuniké 2020 |
2020-10-30 | Kvartalsrapport 2020-Q3 |
2020-07-31 | Kvartalsrapport 2020-Q2 |
2020-04-30 | X-dag ordinarie utdelning NNH 1.75 SEK |
2020-04-29 | Kvartalsrapport 2020-Q1 |
2020-04-29 | Årsstämma |
2020-02-28 | Bokslutskommuniké 2019 |
2019-10-31 | Kvartalsrapport 2019-Q3 |
2019-07-31 | Kvartalsrapport 2019-Q2 |
2019-04-29 | X-dag ordinarie utdelning NNH 1.50 SEK |
2019-04-25 | Kvartalsrapport 2019-Q1 |
2019-04-25 | Årsstämma |
2019-03-01 | Bokslutskommuniké 2018 |
2018-10-31 | Kvartalsrapport 2018-Q3 |
2018-07-31 | Kvartalsrapport 2018-Q2 |
2018-04-27 | X-dag ordinarie utdelning NNH 1.15 SEK |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-04-26 | Årsstämma |
2018-03-02 | Bokslutskommuniké 2017 |
2017-10-31 | Kvartalsrapport 2017-Q3 |
2017-07-31 | Kvartalsrapport 2017-Q2 |
2017-04-28 | X-dag ordinarie utdelning NNH 0.40 SEK |
2017-04-27 | Kvartalsrapport 2017-Q1 |
2017-04-27 | Årsstämma |
2017-03-06 | Bokslutskommuniké 2016 |
2016-10-31 | Kvartalsrapport 2016-Q3 |
2016-07-29 | Kvartalsrapport 2016-Q2 |
2016-04-29 | X-dag ordinarie utdelning NNH 0.25 SEK |
2016-04-28 | Årsstämma |
2016-04-28 | Kvartalsrapport 2016-Q1 |
2016-03-07 | Bokslutskommuniké 2015 |
2015-10-30 | Kvartalsrapport 2015-Q3 |
2015-07-31 | Kvartalsrapport 2015-Q2 |
2015-04-30 | X-dag ordinarie utdelning NNH 0.00 SEK |
2015-04-29 | Kvartalsrapport 2015-Q1 |
2015-04-29 | Årsstämma |
2015-03-06 | Bokslutskommuniké 2014 |
2014-10-31 | Kvartalsrapport 2014-Q3 |
2014-07-31 | Kvartalsrapport 2014-Q2 |
2014-05-01 | X-dag ordinarie utdelning NNH 0.00 SEK |
2014-04-30 | Årsstämma |
2014-03-07 | Bokslutskommuniké 2013 |
2013-10-31 | Kvartalsrapport 2013-Q3 |
2013-07-31 | Kvartalsrapport 2013-Q2 |
2013-04-30 | X-dag ordinarie utdelning NNH 0.00 SEK |
2013-04-29 | Årsstämma |
2013-04-29 | Kvartalsrapport 2013-Q1 |
2013-03-08 | Bokslutskommuniké 2012 |
2012-10-31 | Kvartalsrapport 2012-Q3 |
2012-07-31 | Kvartalsrapport 2012-Q2 |
2012-05-01 | X-dag ordinarie utdelning NNH 0.00 SEK |
2012-04-30 | Årsstämma |
2012-04-30 | Kvartalsrapport 2012-Q1 |
2012-03-09 | Bokslutskommuniké 2011 |
2011-10-31 | Kvartalsrapport 2011-Q3 |
2011-07-29 | Kvartalsrapport 2011-Q2 |
2011-04-29 | Kvartalsrapport 2011-Q1 |
2011-04-29 | Årsstämma |
2011-03-11 | Bokslutskommuniké 2010 |
2010-10-29 | Kvartalsrapport 2010-Q3 |
2010-07-30 | Kvartalsrapport 2010-Q2 |
2010-05-03 | X-dag ordinarie utdelning NNH 0.00 SEK |
2010-04-30 | Kvartalsrapport 2010-Q1 |
2010-02-26 | Bokslutskommuniké 2009 |
2009-10-30 | Kvartalsrapport 2009-Q3 |
2009-07-31 | Kvartalsrapport 2009-Q2 |
2009-04-30 | Kvartalsrapport 2009-Q1 |
2009-04-16 | Årsstämma |
2009-04-14 | X-dag ordinarie utdelning NNH 0.00 SEK |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Handel & varor |
Industri | Detaljhandel |
CEO, Karl Kristian Bergman Jensen and CFO, Marinus Blaabjerg Sørensen both serve the Board of Directors.
This is not in accordance with the First North Rulebook section 2.3.4.
Therefore Nasdaq will put New Nordic Healthbrands AB on observation list until this situation has been resolved.
New Nordic are working to resolve the situation fast and will immediately send out a press release once this has happened.
Malmö January 27, 2020
Karl Kristian Bergman Jensen, CEO
New Nordic Healthbrands AB
Södra Förstadsgatan 3 C
SE-211 43 Malmö
Sweden
This information is information that New Nordic Healthbrands AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation The information was submitted for publication, through the agency of the contact person set out above, at 13:00 (CET) on January 27, 2020.
Contact:
Karl Kristian Bergman Jensen, CEO +46 40-239520 (switchboard),
Marinus Blåbjerg Sørensen, CFO +45 46323344 (switchboard)
New Nordic Healthbrands AB (publ), SE-211 43 Malmö,Sweden Phone +46-40-239520, email: kk@newnordic.com. Registered office: Malmö, Reg. No. 556698-0453.
Certified advisor: Mangold Fondkommission AB. +46 8 503 01 550, e-mail: ca@mangold.se.
The following documents can be retrieved from beQuoted
new nordic pressrelease200127 observation-003.pdf
New Nordic Healthbrands AB (publ) was founded in 1990 and is quoted on Nasdaq First North Growth Market Sweden since 2007. The company's business concept is to offer the most effective and safe food supplements, natural medicines and cosmetic products for specific health and beauty concerns. New Nordic's branded products are now available in 34 countries in pharmacies and health stores. The New Nordic Group has it's own small sales and marketing companies in most European Countries, Canada and the US, to organize local marketing campaigns, serve the pharmacy and health retailers and serve the end consumers. In 2018, sales were 394 MSEK. Nearly all New Nordic products sold worldwide are manufactured in Scandinavia. For further information, visit www.newnordic.com.